Andrew C Don-Wauchope
Affiliation: McMaster University
- Applicability of the AGREE II instrument in evaluating the development process and quality of current National Academy of Clinical Biochemistry guidelinesAndrew C Don-Wauchope
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Clin Chem 58:1426-37. 2012..We assessed the applicability of AGREE II in assessing the National Academy of Clinical Biochemistry (NACB) LMPGs...
- The (mis) use of bone resorption markers in the context of bisphosphonate exposure, dental surgery and osteonecrosis of the jawAndrew C Don-Wauchope
Department of Pathology and Molecular Medicine, McMaster University and Hamilton Regional Laboratory Medicine Program, Canada
Clin Biochem 42:1194-6. 2009..To evaluate the argument for use of bone resorption markers in patients exposed to bisphosphonates and requiring dental surgery to prevent development of osteonecrosis of the jaw...
- Pediatric critical values: laboratory-pediatrician discourseAndrew C Don-Wauchope
Department of Pathology and Molecular Medicine, McMaster University and Hamilton Regional Laboratory Medicine Program, 1200 Main Street West, Hamilton, Ontario, Canada
Clin Biochem 42:1658-61. 2009..To review pediatric critical values after consultation with departmental pediatricians...
- State hospitals, academic medicine and the decline of health care in South Africa: A cry of support from those who have left for those who stayAndrew C Don Wauchope
S Afr Med J 100:74-5. 2010..In particular, the South African public and government needs to acknowledge that poor working conditions and inadequate compensation play a large role in the loss of medical skill from South Africa...
- Missed follow-up opportunities using a two-step screening approach for gestational diabetesJohn L Sievenpiper
Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
Diabetes Res Clin Pract 96:e43-6. 2012..Adherence was sub-optimal. Overall follow-up was missed in 14.5% of those screened. Only 36% of those who met dysglycemia criteria for a follow-up 75 g-OGTT received the test as per step 2 of the protocol...